임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
36건 표시
- 3상모집 중단 (진행 중)· COVID-19A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
리드: 바이오엔테크 · 협력: 화이자
- 3상모집 중단 (진행 중)· Lyme BorreliosisA Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adults
리드: 화이자
- 3상모집 중단 (진행 중)· Severe Alopecia AreataA Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata
리드: 화이자
- 3상모집 중단 (진행 중)· Alopecia AreataA Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
리드: 화이자
- 3상모집 중단 (진행 중)· Metastatic Castrate Resistant Prostate Cancer (mCRPC)A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).
리드: 화이자
- 3상모집 중단 (진행 중)· Carcinoma, Non-Small-Cell LungA Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
리드: 화이자
- 3상모집 중단 (진행 중)· Stable Nonsegmental VitiligoA 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2
리드: 화이자
- 3상모집 중단 (진행 중)· Urothelial CarcinomaDisitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2
리드: 화이자 · 협력: 머크(MSD)
- 3상모집 중단 (진행 중)· Breast CancerVepdegestrant (ARV-471/PF-07850327) + Palbociclib vs Letrozole + Palbociclib in ER(+)/HER2(-) Advanced Breast Cancer
리드: 화이자
- 3상모집 중단 (진행 중)· Advanced Breast CancerA Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer
리드: 화이자
- 3상모집 중단 (진행 중)· SARS-CoV-2 VirusA Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
리드: 바이오엔테크 · 협력: 화이자
- 3상모집 중단 (진행 중)· Multiple MyelomaStudy With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant
리드: 화이자
- 3상모집 중단 (진행 중)· HER2 Positive Breast CancerA Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer
리드: 화이자
- 3상모집 중단 (진행 중)· Advanced MalignanciesContinued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing
리드: 화이자
- 3상모집 중단 (진행 중)· Lower Respiratory Tract IllnessStudy to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults.
리드: 화이자
- 3상모집 중단 (진행 중)· Ulcerative ColitisEvaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis
리드: 화이자
- 3상모집 중단 (진행 중)· Prostate CancerStudy of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC
리드: 화이자
- 3상모집 중단 (진행 중)· MelanomaA Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma
리드: 화이자 · 협력: 머크(MSD)
- 3상모집 중단 (진행 중)· NeoplasmsA Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
리드: 화이자 · 협력: 일라이 릴리
- 3상모집 중단 (진행 중)· Duchenne Muscular DystrophyStudy to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy
리드: 화이자
- 3상모집 중단 (진행 중)· Diffuse Large B-cell LymphomaBrentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL
리드: 화이자
- 3상모집 중단 (진행 중)· Non-muscle Invasive Bladder CancerA Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer
리드: 화이자
- 3상모집 중단 (진행 중)· HER2-positive Breast CancerA Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer
리드: 화이자
- 3상모집 중단 (진행 중)· Ulcerative ColitisAn Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
리드: 화이자
- 3상모집 중단 (진행 중)· Breast Cancer RecurrentPalbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer
협력: 화이자
- 3상모집 중단 (진행 중)· HER-2 Positive Breast CancerRandomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer
협력: 화이자
- 3상모집 중단 (진행 중)· Carcinoma, Non-Small-Cell LungA Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC
리드: 화이자
- 3상모집 중단 (진행 중)· Acute Myeloid LeukaemiaInternational Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia
협력: 화이자
- 3상모집 중단 (진행 중)· Hormone Sensitive Prostate CancerSafety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
리드: 화이자
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.